Similarly, the predictive role of OX40 (TNFRSF4) and GITR (TNFRSF18, AITR) methylation has been highlighted for use after immunotherapy for HNSCC, in addition to their prognostic role discussed earlier [50]. Here, TNFRSF4 is linked to head and neck squamous cell carcinoma.